RESUMEN
AIMS: To describe the incidence and epidemiology of conjunctival squamous cell carcinoma (CSCC) in South Africa over a 25-year period (1994-2018), with particular reference to the HIV epidemic. METHODS: Incident cases of histologically diagnosed CSCC were identified from the pathology-based South African National Cancer Registry. Crude and direct age-standardised incidence rates (ASIRs) per 100 000 persons (Segi World Standard Population) were calculated using national population statistics and compared by age, sex and ethnicity. Trends in the incidence and demographic features of CSCC were described and analysed. Incidence rates were compared with national HIV-related statistics for the same time period. RESULTS: In total, there were 9016 reported CSCC cases (women: 56.6%, black: 86.8%, mean age: 41.5 years). The overall ASIR was 0.78 per 100 000. Two distinct epidemiological patterns were identified: (1) older white men, and (2) younger black women. There was a sixfold increase in CSCC incidence rates between 1994 and 2009 with a corresponding shift from the first to the second disease profile. Despite rising HIV seroprevalence, CSCC incidence rates have declined since 2009. A strong ecological correlation (r=0.96) between CSCC incidence and widespread antiretroviral therapy (ART) provision was identified. CONCLUSION: This study highlights the evolving trends and disease burden of CSCC in South Africa. Widespread ART provision is ecologically correlated with declining CSCC rates over the last decade. These findings are in keeping with reported trends for other HIV-related cancers and have important implications for future incidence studies and public health policy.
RESUMEN
PURPOSE: To report a rare case of herpes virus type 2-related conjunctivitis, resistant to aciclovir (ACV). METHODS: Case report and review of literature. RESULTS: A 28-year-old human immunodeficiency virus-positive man presented with chronic, recurrent follicular conjunctivitis. Multiplex reverse transcription polymerase chain reaction assay testing was positive for herpes simplex virus (HSV); subsequent typing with HSV assay revealed the presence of HSV type 2. Oral ACV failed to control the disease, and the patient continued to worsen clinically until resistance testing was performed. This revealed an M183stop within thymidine kinase, thus confirming the suspected resistance. The patient improved after 14 days of high-dose continuous intravenous infusion of ACV. CONCLUSIONS: This is a rare case of isolated conjunctivitis due to herpes virus type 2, in an human immunodeficiency virus-positive patient, which was found to be resistant to ACV. Drug-resistant HSV is likely to emerge as an important clinical entity in the future, increasing the need for new drugs with novel mechanisms of action.
Asunto(s)
Aciclovir/farmacología , Conjuntivitis/tratamiento farmacológico , Farmacorresistencia Viral , Infecciones Virales del Ojo/tratamiento farmacológico , Herpes Simple/tratamiento farmacológico , Adulto , Antivirales/farmacología , Conjuntivitis/virología , Infecciones Virales del Ojo/virología , Herpes Simple/virología , Herpesvirus Humano 1/genética , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , ARN Viral/análisisRESUMEN
PURPOSE: To report the clinical presentation (systemic and ocular) of hydroa vacciniforme in a Black South African child. METHODS: Case report. RESULTS: A 14-year-old Black boy was seen at the corneal service with cutaneous erosions, varioliform scarring, corneal scarring, cicatricial conjunctivitis and central crystalline corneal opacity. CONCLUSION: We report the first case in the literature of ocular hydroa vacciniforme in a young Black South Africa boy.
Asunto(s)
Opacidad de la Córnea/patología , Hidroa Vacciniforme/complicaciones , Baja Visión/patología , Adolescente , Conjuntiva/patología , Córnea/patología , Humanos , MasculinoAsunto(s)
Segmento Anterior del Ojo/anomalías , Opacidad de la Córnea/cirugía , Sustancia Propia/patología , Lámina Limitante Posterior/patología , Endotelio Corneal/patología , Anomalías del Ojo/cirugía , Queratoplastia Penetrante/métodos , Agudeza Visual , Segmento Anterior del Ojo/cirugía , Niño , Opacidad de la Córnea/diagnóstico , Anomalías del Ojo/diagnóstico , Femenino , Humanos , Tomografía de Coherencia ÓpticaRESUMEN
Keratoconus is a common degenerative corneal disease that can lead to significant visual morbidity, and both genetic and environmental factors have been implicated in its pathogenesis. We compared the transcriptome of keratoconus and control epithelium using RNA-Seq. Epithelial tissues were obtained prior to surgery from keratoconus and myopia control patients, undergoing collagen cross-linking and photorefractive keratectomy, respectively. We identified major differences in keratoconus linked to cell-cell communication, cell signalling and cellular metabolism. The genes associated with the Hedgehog, Wnt and Notch1 signaling pathways were down-regulated in keratoconus. We also identified plasmolipin and Notch1 as being significantly reduced in keratoconus for both gene and protein expression (p < 0.05). Plasmolipin is a novel protein identified in human corneal epithelium, and has been demonstrated to have a key role in epithelial cell differentiation in other tissues. This study shows altered gene and protein expression of these three proteins in keratoconus, and further studies are clearly warranted to confirm the functional role of these proteins in the pathogenesis of keratoconus.
Asunto(s)
Epitelio Corneal/metabolismo , Perfilación de la Expresión Génica/métodos , Queratocono/genética , Miopía/genética , Análisis de Secuencia de ARN/métodos , Adolescente , Adulto , Femenino , Regulación de la Expresión Génica , Redes Reguladoras de Genes , Humanos , Queratocono/metabolismo , Masculino , Persona de Mediana Edad , Proteínas Proteolipídicas Asociadas a Mielina y Linfocito/genética , Proteínas Proteolipídicas Asociadas a Mielina y Linfocito/metabolismo , Miopía/metabolismo , Receptor Notch1/genética , Receptor Notch1/metabolismo , Vía de Señalización Wnt , Adulto JovenAsunto(s)
Edema Corneal/inducido químicamente , Receptores ErbB/antagonistas & inhibidores , Clorhidrato de Erlotinib/efectos adversos , Anciano , Antineoplásicos/administración & dosificación , Antineoplásicos/efectos adversos , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Carcinoma de Pulmón de Células no Pequeñas/metabolismo , Edema Corneal/diagnóstico , Relación Dosis-Respuesta a Droga , Sustitución de Medicamentos , Epitelio Corneal/efectos de los fármacos , Epitelio Corneal/patología , Receptores ErbB/metabolismo , Clorhidrato de Erlotinib/administración & dosificación , Estudios de Seguimiento , Gefitinib , Humanos , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/metabolismo , Masculino , Quinazolinas/uso terapéuticoRESUMEN
PURPOSE: To report the safety and efficacy of descemetorhexis without grafting as a primary intervention in Fuchs dystrophy, and the use of a ROCK inhibitor, ripasudil as a salvage agent in failing cases. METHODS: Twelve eyes of 11 patients underwent central descemetorhexis not exceeding 4 mm. All had Fuchs dystrophy-producing visual symptoms, requesting intervention. Exclusion criteria were a peripheral endothelial cell count <1000 and central edema. Corneal clearance and visual parameters were recorded monthly until corneal clearance was observed, then at intervals of 6 months. Cases failing to clear by month 2 were considered for salvage treatment. This consisted of treatment with 1 of 2 formulations of Rho-associated kinase inhibitor eye drops. Endothelial keratoplasty was planned as the final salvage procedure in unsuccessful cases. RESULTS: Nine of 12 eyes cleared spontaneously between 2 and 6 months. One eye failed to clear by month 5 and topical Y-27632 was administered, without success. Endothelial keratoplasty was performed. In 2 eyes, healing stalled at 3 and 2 months. In both cases, topical ripasudil administered 6 times a day for 2 weeks resulted in complete corneal clearance. In cases achieving corneal clearance, best spectacle corrected visual acuity improved from a mean of 0.26 to 0.125 (logMAR) with subjective improvement in quality of vision. CONCLUSIONS: In Fuchs dystrophy with visual degradation due to central guttae, descemetorhexis without grafting is a viable procedure for visual rehabilitation. Careful patient selection is required, but the advent of topical ripasudil as a salvage agent suggests that a broader application of the surgery may be possible. Further study into the use of this agent is now needed.
Asunto(s)
Lámina Limitante Posterior/cirugía , Distrofia Endotelial de Fuchs/terapia , Isoquinolinas/uso terapéutico , Sulfonamidas/uso terapéutico , Quinasas Asociadas a rho/antagonistas & inhibidores , Administración Tópica , Adulto , Anciano , Recuento de Células , Terapia Combinada , Queratoplastia Endotelial de la Lámina Limitante Posterior , Femenino , Estudios de Seguimiento , Distrofia Endotelial de Fuchs/tratamiento farmacológico , Distrofia Endotelial de Fuchs/fisiopatología , Distrofia Endotelial de Fuchs/cirugía , Humanos , Masculino , Persona de Mediana Edad , Soluciones Oftálmicas , Estudios Prospectivos , Refracción Ocular/fisiología , Agudeza Visual/fisiologíaRESUMEN
PURPOSE: Collagen cross-linking (CXL) is a commonly performed procedure to prevent the progression of keratoconus. Riboflavin is an essential part of the procedure, which facilitates both the cross-linking process and protection of intraocular structures. Dextran can be added to riboflavin to create an isotonic solution. This case report highlights the importance of compounding riboflavin with the correct dextran solution. METHODS: A retrospective case series. RESULTS: Six eyes of 4 male patients with keratoconus aged from 20 to 38 years underwent CXL with substitution of 20% dextran (T-500) with 20% dextran sulfate in a compounded riboflavin 0.1% solution. Postoperatively, persistent corneal epithelial defects, stromal haze, and then scarring occurred. Corneal transplantation was performed for visual rehabilitation but was complicated by graft rejection followed by failure (n = 1 eye), dehiscence (n = 4), cataract (n = 2), post-laser ablation haze (n = 1), and steroid-induced glaucoma (n = 2). The visual outcome was <6/18 in all 6 cases because of irregular astigmatism and stromal haze. Thinning, vascularization, and scarring of the residual host tissue were noted. CONCLUSIONS: Substitution of dextran (T-500) with dextran sulfate in riboflavin solutions during CXL results in loss of vision from permanent corneal opacity. Residual host changes may compromise the results of corneal transplantation.
Asunto(s)
Opacidad de la Córnea/inducido químicamente , Reactivos de Enlaces Cruzados , Sulfato de Dextran/efectos adversos , Dextranos/uso terapéutico , Epitelio Corneal/efectos de los fármacos , Queratocono/tratamiento farmacológico , Riboflavina/uso terapéutico , Adulto , Colágeno/metabolismo , Opacidad de la Córnea/diagnóstico , Opacidad de la Córnea/cirugía , Sustancia Propia/metabolismo , Composición de Medicamentos , Sustitución de Medicamentos , Epitelio Corneal/patología , Humanos , Queratocono/metabolismo , Queratoplastia Penetrante , Masculino , Fármacos Fotosensibilizantes/uso terapéutico , Estudios Retrospectivos , Rayos Ultravioleta , Agudeza Visual/efectos de los fármacos , Adulto JovenRESUMEN
PURPOSE: Syphilitic interstitial keratitis is a stromal inflammatory disease with characteristic secondary vascularization. This case illustrates a late complication of hemorrhagic Descemet membrane detachment. METHODS: Case report. RESULTS: The patient presented with painless sudden visual loss and progressive shallowing of the anterior chamber caused by hemorrhagic Descemet membrane detachment. She had corneal neovascularization and a positive syphilis serology. Owing to the risk of pupil block glaucoma, the patient had surgical drainage of the blood via an ab externo approach. CONCLUSIONS: This case illustrates a previously unreported complication of syphilitic interstitial keratitis. The patient recovered good visual acuity and had residual pigment deposits in the pre-Descemet interface.